Negative News from Ionis Pharmaceuticals Phase 3 Trial for Huntington’s Disease. Good News from the Regeneron Antibody Cocktail for COVID-19

Negative News from Ionis Pharmaceuticals 
Ionis Pharmaceuticals (IONS) announced that its partner, Roche (RHHBY),

This content is for paid subscribers.
Please click here to subscribe or here to log in.